Develop and Validate Transferrin Receptor

The National Human Genome Research Institute, Division of Intramural Research (NHGRI) is seeking to develop and validate a Transferrin Receptor. The proposed contractor is Creative Biolabs, and the justification for sole source is that they are the only known responsible source capable of providing the required services that meet NHGRI compatibility and continuity requirements. The company will transfer all resulting intellectual property and associated materials to the NIH under a Materials Transfer Agreement (MTA). • The requirement is for a customized humanized antibody library screening service that meets specific technical requirements. • Creative Biolabs possesses the specialized expertise, proprietary capabilities, and experience necessary to perform this customized screening. • The NIH will retain ownership of the resulting technology and pursue commercialization following successful preclinical development, clinical trials, and any required regulatory approvals. • Small businesses may submit a written capability statement demonstrating their ability to perform the requirement.